Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Sentinel lymph node mapping with superparamagnetic iron oxide for melanoma: a pilot study in healthy participants to establish an optimal MRI workflow protocol

Fig. 2

Pre- and post-injection (0.5 ml) T1-weighted coronal images of the anterior upper trunk in participant one. A Image before tracer injection. B Image of injection site showing a large decrease in signal. C Image of lymphatic tracer uptake in right axillary LN, one hour post-injection. The first LN showing a large decreased signal and therefore considered to be the SLN, indicated with the white circle

Back to article page